Answers are grounded in this paper and cite their sources.
Narrative review addresses psychotropic drug use in dermatology, suggesting practical guidance for clinicians.
In the routine clinical practice in dermatology, there is a high burden of psychiatric morbidity due to primary psychiatric disorders that secondarily affect the skin or dermatological disorders that secondarily can have a profound psychosocial and mental health impact. We present a narrative review on the use of psychotropic drugs, with the aim of addressing the intersection between mental health and dermatology. The article aims to be a practical guide, providing clear and concise recommendations on the indications, dosing, adverse effects, special considerations, or contraindications of the most widely used drugs today, with the goal of providing dermatologists with the basic tools for the appropriate global therapeutic management of these patients.
No takes yet. Share an insight, caveat, or question.
Carmona‐Rocha et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: